SCM
Silverarc Capital Management’s Aclaris Therapeutics ACRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Hold |
0
| – | – | – | 65 |
|
|
2023
Q3 | – | Sell |
-219,229
| Closed | -$2.27M | – | 69 |
|
|
2023
Q2 | $2.27M | Sell |
219,229
-871
| -0.4% | -$9.03K | 0.7% | 38 |
|
|
2023
Q1 | $1.78M | Sell |
220,100
-132,093
| -38% | -$1.07M | 0.74% | 42 |
|
|
2022
Q4 | $5.55M | Sell |
352,193
-191,583
| -35% | -$3.02M | 1.59% | 18 |
|
|
2022
Q3 | $8.56M | Buy |
543,776
+4,231
| +0.8% | +$66.6K | 2.9% | 8 |
|
|
2022
Q2 | $7.53M | Buy |
539,545
+264,212
| +96% | +$3.69M | 2.32% | 8 |
|
|
2022
Q1 | $4.75K | Sell |
275,333
-10,893
| -4% | -$188 | 1.96% | 11 |
|
|
2021
Q4 | $4.16M | Buy |
286,226
+112,899
| +65% | +$1.64M | 1.69% | 18 |
|
|
2021
Q3 | $3.12M | Sell |
173,327
-15,392
| -8% | -$277K | 1.76% | 20 |
|
|
2021
Q2 | $3.31K | Sell |
188,719
-148,018
| -44% | -$2.6K | 1.48% | 20 |
|
|
2021
Q1 | $8.49M | Buy |
+336,737
| New | +$8.49M | 4.63% | 1 |
|